Giles W Robinson Selected Research

Giles W Robinson Research Topics

24	Neoplasms (Cancer) 01/2024 - 04/2014
23	Medulloblastoma 01/2023 - 11/2013
14	Brain Neoplasms (Brain Tumor) 01/2024 - 04/2014
4	Glioma (Gliomas) 01/2024 - 04/2014
3	Hearing Loss (Hearing Impairment) 12/2019 - 03/2015
2	Typical Teratoid Rhabdoid Tumor 01/2023 - 01/2017
2	Central Nervous System Neoplasms 10/2022 - 01/2021
2	Neuroblastoma 10/2022 - 05/2017
2	Choroid Plexus Carcinoma 01/2021 - 01/2016
2	Pinealoma (Pineoblastoma) 01/2020 - 01/2020
2	Neurologic Manifestations (Neurological Manifestations) 12/2019 - 01/2018
2	Ependymoma 10/2019 - 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Sarcoma (Soft Tissue Sarcoma) 10/2022
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2022
1	Primitive Neuroectodermal Tumors (PNET) 10/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Craniopharyngioma (Craniopharyngiomas) 11/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Scoliosis 12/2019
1	Paresthesia (Dysesthesia) 12/2019
1	Paralysis (Palsy) 12/2019
1	Avian Reticuloendotheliosis 10/2019
1	Residual Neoplasm 01/2019
1	Cognitive Dysfunction 01/2019
1	Carcinogenesis 11/2018
1	Astrocytoma (Pilocytic Astrocytoma) 01/2018
1	Rhabdoid Tumor (Rhabdoid Tumors) 05/2017
1	Retinoblastoma (Glioblastoma, Retinal) 05/2017
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Fatigue 05/2017
1	Ascites 01/2017
1	Ototoxicity 03/2015
1	Glioblastoma (Glioblastoma Multiforme) 04/2014
1	Melanoma (Melanoma, Malignant) 04/2014

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
3	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2021
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	Methionine (L-Methionine)FDA Link 01/2024 - 01/2022
2	ribociclibIBA 01/2022 - 05/2017
2	Gemcitabine FDA Link 01/2022 - 04/2014
2	VemurafenibIBA 01/2018 - 04/2014
2	HhAntag691IBA 09/2017 - 08/2015
2	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 03/2015
1	Amino Acids FDA Link 01/2024
1	MLN 8237IBA 01/2023
1	entrectinibIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	Circulating Tumor DNAIBA 01/2022
1	lorlatinibIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	tyrosyltyrosine (Tyr-Tyr)IBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	pomalidomideIBA 01/2021
1	InterferonsIBA 11/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	ProteomeIBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Complement System Proteins (Complement)IBA 11/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2017
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 11/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2017
1	Cyclin DIBA 05/2017
1	NucleosidesIBA 01/2016
1	TetrahydrouridineIBA 01/2016
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2016
1	5-fluoro-2'-deoxycytidineIBA 01/2016
1	Pemetrexed (MTA)FDA Link 04/2014

29	Therapeutics 01/2024 - 04/2014
8	Drug Therapy (Chemotherapy) 01/2023 - 07/2014
5	Radiotherapy 01/2022 - 01/2019
3	Craniospinal Irradiation 01/2023 - 09/2015
1	Duration of Therapy 10/2022
1	Maintenance Chemotherapy 10/2019
1	Consolidation Chemotherapy 10/2019
1	Ventriculoperitoneal Shunt 01/2017
1	Aftercare (After-Treatment) 09/2015